Announcements Trials
Browse Landscape

Phase

Phase 2 244Phase 3 213Phase 1 173Phase 1/2 127Phase 2/3 27Phase 4 7Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 43NIH 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Mammography 12Radiofrequency Ablation 9Blood Specimen Collection 9Standard of Care 8Drug Delivery Systems 8Colonoscopy 8Uterine Myomectomy 6Robotic Surgical Procedures 6Colposcopy 6Biopsy 6Proton Therapy 5Inositol 5Cryosurgery 5Therapeutics 4Surgical Procedures, Operative 4Radiotherapy 4Leukapheresis 4Food 4Drug Therapy 4Cryotherapy 4Cisplatin 4CF regimen 4Brachytherapy 4pegylated granulocyte colony-stimulating factor 3exemestane 3epigallocatechin gallate 3Uterine Artery Embolization 3Sunitinib 3Paclitaxel 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Gemcitabine × Clear all
NCT04894643 2026-03-20

PARC

EBG MedAustron GmbH

Phase NA Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06611345 2024-10-26

A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

Phase NA Recruiting
60 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡